Camidanlumab (HuMax-TAC) is a CD25 моноклональный антитело. Camidanlumab targets the клетка-surface antigen CD25, which is over-expressed on a variety of hematological tumors and shows limited expression on normal tissues. Camidanlumab can be used for synthesis of антитело agent conjugates (ADCs) to research several diseases including lymphoma and leukemia.
Camidanlumab (HuMax-TAC) is a CD25 monoclonal antibody. Camidanlumab targets the cell-surface antigen CD25, which is over-expressed on a variety of hematological tumors and shows limited expression on normal tissues. Camidanlumab can be used for synthesis of antibody agent conjugates (ADCs) to research several diseases including lymphoma and leukemia.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.